AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The Future of Rheumatology
There are a lot more biomarkers being identified. I think over time, as we can get some of these lab tests that are clinically available and rapidly returned, it's really going to help us manage and identify patients. And then there are groups of patients that traditionally just have not done well with anything. That's particularly malignancy associated HLA, which is extremely difficult to manage.